Cross-Protective Immunity against O`Nyong-nyong Virus Afforded by a Novel Recombinant Chikungunya Vaccine

Emerging mosquito-borne alphavirus infections caused by chikungunya virus (CHIKV) oro`nyong-nyong virus (ONNV) are responsible for sporadic and sometimes explosive urban outbreaks. Currently, there is no licensed vaccine against either virus. We have developed a highly attenuated recombinant CHIKV c...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Partidos, Charalambos D., Paykel, Joanna, Weger, James, Borland, Erin M., Powers, Ann M., Seymour, Robert, Weaver, Scott C., Stinchcomb, Dan T., Osorio, Jorge E.
Formato: Artigo
Lenguaje:Inglês
Publicado: 2012
Materias:
Article
Acceso en línea:https://ncbi.nlm.nih.gov/pmc/articles/PMC3372665/
https://ncbi.nlm.nih.gov/pubmed/22583812
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.vaccine.2012.04.099
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares